|
ISCA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.50009999977385E-08 |
| Normal-vs-Stage3 |
8.50780002004115E-10 |
| Normal-vs-Stage4 |
4.47889999977136E-07 |
| Stage1-vs-Stage2 |
2.488600E-01 |
| Stage1-vs-Stage3 |
5.587800E-01 |
| Stage1-vs-Stage4 |
1.999200E-01 |
| Stage2-vs-Stage3 |
6.093800E-01 |
| Stage2-vs-Stage4 |
7.184600E-01 |
| Stage3-vs-Stage4 |
4.220600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.01816341416361E-12 |
| Normal-vs-Asian |
2.674400E-02 |
| Caucasian-vs-AfricanAmerican |
8.541600E-02 |
| Caucasian-vs-Asian |
8.118800E-01 |
| AfricanAmerican-vs-Asian |
4.862000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.44249065417534E-15 |
| Male-vs-Female |
2.106600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.77202696960421E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.99840144432528E-15 |
| Normal-vs-Extreme_Obese |
2.343800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.684400E-01 |
| Normal_Weight-vs-Obese |
9.896200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.663600E-01 |
| Extreme_Weight-vs-Obese |
6.199600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.917400E-01 |
| Obese-vs-Extreme_Obese |
3.625400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.2757024283685E-11 |
| Normal-vs-Age(41-60Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.2805979327245E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.075200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.946400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.237000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.044200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.424050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.297200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.99840144432528E-15 |
| Normal-VS-KIRP CIMP |
3.0060000000276E-06 |
| Normal-VS-Unclassified PRCC |
1.62525548574877E-12 |
| Type1 PRCC-VS-Type2 PRCC |
8.770200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.157550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.296400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.121600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.360000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.251700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6251444634463E-12 |
| Normal-vs-N1 |
7.53900000205476E-08 |
| Normal-vs-N2 |
3.65060000000472E-05 |
| N0-vs-N1 |
4.057000E-01 |
| N0-vs-N2 |
9.158400E-01 |
| N1-vs-N2 |
6.558800E-01 |
|
|
